Dna, D(3'-Amino-3'-Deoxy-P-Thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-Hydroxy-3-((1-Oxohexadecyl)Amino)Propyl) Hydrogen Phosphorothioate)
Breast Carcinoma
Geron Corporationnucleic_acidPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
209 Active assets in the Breast Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Trastuzumab SWOG Cancer Research Network | Phase 4 | BBB |
Zoledronate Washington University School of Medicine | Phase 4 | BBB |
Pertuzumab SWOG Cancer Research Network | Phase 3 | BBB |
Tamoxifen Dartmouth-Hitchcock Medical Center | Phase 4 | BBB |
Trastuzumab Deruxtecan SWOG Cancer Research Network | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Dna, D(3'-Amino-3'-Deoxy-P-Thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-Hydroxy-3-((1-Oxohexadecyl)Amino)Propyl) Hydrogen Phosphorothioate) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →